These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10809629)

  • 1. Glucose, free fatty acids, and insulin secretion.
    Nutr Rev; 1970 Apr; 28(4):93-5. PubMed ID: 10809629
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose, free fatty acids, and insulin secretion.
    Padiatr Grenzgeb; 1969; 8(1):93-5. PubMed ID: 4910298
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucagon mediated insulin release in man].
    Marks V; Salmols E
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():285-308. PubMed ID: 4907221
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma insulin, glucagon, and nonesterified fatty acids in dogs with diabetes mellitus.
    Manns JG; Martin CL
    Am J Vet Res; 1972 May; 33(5):981-5. PubMed ID: 5023056
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of repetitive glucose loads on plasma concentrations of glucose, insulin and free fatty acids: paradoxical insulin responses in subjects with mild glucose intolerance.
    Metz R; Friedenberg R
    J Clin Endocrinol Metab; 1970 May; 30(5):602-8. PubMed ID: 4910526
    [No Abstract]   [Full Text] [Related]  

  • 6. Free fatty acids and insulin secretion in humans.
    Boden G
    Curr Diab Rep; 2005 Jun; 5(3):167-70. PubMed ID: 15929861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secretion of insulin and disorders in fatty acid metabolism in diabetic patients with coronary heart diseases].
    Lohmann D; Liebold F; Heilman W
    Z Gesamte Inn Med; 1975 Jun; 30(12):84-6. PubMed ID: 1199269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus: disease or syndrome?].
    Lestradet H
    Nouv Presse Med; 1972 Oct; 1(38):2555-8. PubMed ID: 5081782
    [No Abstract]   [Full Text] [Related]  

  • 10. [Course of immunoreactive insulin, glycemia and fatty acid levels after stimulation with glucose and aminophylline].
    Bartos V; Maláková B; Spĕváková A; Vísek V; Krombholzová L; Musil J; Kimlová I; Prokopec J
    Vnitr Lek; 1975 Mar; 21(3):261-8. PubMed ID: 1119105
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathways from obesity to diabetes.
    Felber JP; Golay A
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 2():S39-45. PubMed ID: 12174327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of therapy on glucose and lipid metabolism as well as insulin secretion in diabetes mellitus].
    Lohmann D; Verlohren HJ; Pohl A; Brückner U
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(2):77-84. PubMed ID: 1017406
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
    Boden G
    Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cortisol on the tolerance to glucose of thyroidectomized calves.
    Edwards AV; Nathanielsz PW; Vaughan NJ
    J Endocrinol; 1971 Nov; 51(3):511-20. PubMed ID: 5122830
    [No Abstract]   [Full Text] [Related]  

  • 16. [Obesity and diabetes. Recent acquisitions in pathogenetic relationships].
    Giorgino R
    Recenti Prog Med; 1971 Nov; 51(5):438-54. PubMed ID: 5172397
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone.
    Sreenan S; Sturis J; Pugh W; Burant CF; Polonsky KS
    Am J Physiol; 1996 Oct; 271(4 Pt 1):E742-7. PubMed ID: 8897863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence of a reduction of insulin secretion in diabetes with or without obesity. Discussion of the therapeutic use of biguanides].
    Luyckx A; Lefebvre P
    Ann Endocrinol (Paris); 1969; 30(6):717-30. PubMed ID: 5384987
    [No Abstract]   [Full Text] [Related]  

  • 19. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
    Paolisso G; Tagliamonte MR; Rizzo MR; Gualdiero P; Saccomanno F; Gambardella A; Giugliano D; D'Onofrio F; Howard BV
    Diabetologia; 1998 Oct; 41(10):1127-32. PubMed ID: 9794097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free fatty acids and glucose in the blood of insulin resistant diabetics].
    Fischer U; Lippmann HG
    Z Gesamte Inn Med; 1968 Aug; 23(15):Suppl:226-8. PubMed ID: 5678679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.